Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Researchers have finally mapped the 3D structure of the trans-spliceosome — a molecular machine critical to the survival of parasites that cause leishmaniasis, sleeping sickness, and Chagas' disease. Using cryo-electron microscopy, scientists captured the machine in action at near-atomic resolution. The discovery, nearly four decades in the making, opens a promising new door for drug development targeting these hard-to-treat tropical diseases.
For nearly 40 years, scientists knew that trypanosomatid parasites — the culprits behind leishmaniasis, sleeping sickness, and Chagas' disease — relied on a unique molecular process called Spliced Leader (SL) RNA trans-splicing to survive. But exactly how the machine running that process worked remained a mystery. Now, researchers from the University of Liège and Rockefeller University have finally cracked it open.
Using cryogenic electron microscopy (cryo-EM), the team captured two successive snapshots of the trans-spliceosome in action at near-atomic resolution — revealing how its components are organized, how RNAs are positioned during the reaction, and the role of proteins found only in these parasites and not in humans. That last point is key: because this machinery doesn't exist in human cells, it's a highly attractive drug target.
Key Takeaways:
Why it matters: Tropical diseases caused by trypanosomatids affect millions of people globally and cause significant economic losses through livestock and crop infections. This structural blueprint gives drug developers a concrete molecular target to design therapies that are both effective and selective — a major step forward in the fight against neglected tropical diseases.
